ARTICLE | Clinical News
BMJ publishes 'transparency scorecard'
November 13, 2015 2:44 AM UTC
In a GlaxoSmithKline plc (NYSE:GSK; LSE:GSK) and Johnson & Johnson (NYSE:JNJ) reported results from 100% of clinical trials.
According to the paper, Gilead Sciences Inc. (NASDAQ:GILD) was the least transparent, publicly reporting results from 21% of trials that supported approval of Stribild elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate. ...